Bruce F Bell
Examiner (ID: 11075)
Most Active Art Unit | 1741 |
Art Unit(s) | 1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102 |
Total Applications | 2788 |
Issued Applications | 2338 |
Pending Applications | 153 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 19368242
[patent_doc_number] => 12060311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-13
[patent_title] => Method for producing aromatic nitrile by ammoxidation reaction
[patent_app_type] => utility
[patent_app_number] => 16/970581
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 8952
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970581
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/970581 | Method for producing aromatic nitrile by ammoxidation reaction | Mar 17, 2019 | Issued |
Array
(
[id] => 16720037
[patent_doc_number] => 20210087184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => AMINO-BENZOISOTHIAZOLE AND AMINO-BENZOISOTHIADIAZOLE AMIDE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/977929
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13789
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -115
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977929
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977929 | AMINO-BENZOISOTHIAZOLE AND AMINO-BENZOISOTHIADIAZOLE AMIDE COMPOUNDS | Mar 13, 2019 | Abandoned |
Array
(
[id] => 14531463
[patent_doc_number] => 20190201352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => DESIGN, SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXMIER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/299379
[patent_app_country] => US
[patent_app_date] => 2019-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16299379
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/299379 | DESIGN, SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXMIER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY | Mar 11, 2019 | Abandoned |
Array
(
[id] => 16657340
[patent_doc_number] => 20210053976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => SPIROCYCLIC ROR-GAMMA MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/979833
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 288
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16979833
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/979833 | Spirocyclic ROR-gamma modulators | Mar 10, 2019 | Issued |
Array
(
[id] => 18964161
[patent_doc_number] => 11897911
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Nucleotide precursors, nucleotide analogs and oligomeric compounds containing the same
[patent_app_type] => utility
[patent_app_number] => 16/978603
[patent_app_country] => US
[patent_app_date] => 2019-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 80539
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16978603
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/978603 | Nucleotide precursors, nucleotide analogs and oligomeric compounds containing the same | Mar 5, 2019 | Issued |
Array
(
[id] => 16444823
[patent_doc_number] => 10836735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => Compositions and methods for treating cancers
[patent_app_type] => utility
[patent_app_number] => 16/292011
[patent_app_country] => US
[patent_app_date] => 2019-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 25
[patent_no_of_words] => 29555
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16292011
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/292011 | Compositions and methods for treating cancers | Mar 3, 2019 | Issued |
Array
(
[id] => 16525162
[patent_doc_number] => 20200399242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => NOVEL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/977249
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977249
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977249 | NOVEL COMPOUNDS | Feb 28, 2019 | Pending |
Array
(
[id] => 19291533
[patent_doc_number] => 12030879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Sulfonyl acetamides as NLRP3 inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/977445
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68393
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977445
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977445 | Sulfonyl acetamides as NLRP3 inhibitors | Feb 28, 2019 | Issued |
Array
(
[id] => 18932239
[patent_doc_number] => 11884645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Sulfonyl acetamides as NLRP3 inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/977452
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37549
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977452
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977452 | Sulfonyl acetamides as NLRP3 inhibitors | Feb 28, 2019 | Issued |
Array
(
[id] => 18187486
[patent_doc_number] => 11578054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Compounds useful as immunomodulators
[patent_app_type] => utility
[patent_app_number] => 16/977374
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20949
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977374
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977374 | Compounds useful as immunomodulators | Feb 27, 2019 | Issued |
Array
(
[id] => 14501035
[patent_doc_number] => 20190194172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => PYRAZINE DERIVATIVES WITH EXTENDED CONJUGATION AND METHODS OF USING THE SAME IN OPTICAL APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 16/289509
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289509
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/289509 | PYRAZINE DERIVATIVES WITH EXTENDED CONJUGATION AND METHODS OF USING THE SAME IN OPTICAL APPLICATIONS | Feb 27, 2019 | Abandoned |
Array
(
[id] => 14500993
[patent_doc_number] => 20190194151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/289235
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289235
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/289235 | ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF | Feb 27, 2019 | Abandoned |
Array
(
[id] => 17299392
[patent_doc_number] => 20210395231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => RECEPTOR INHIBITORS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/971702
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35968
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971702
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/971702 | Receptor inhibitors, pharmaceutical compositions comprising the same and use thereof | Feb 21, 2019 | Issued |
Array
(
[id] => 18733409
[patent_doc_number] => 11802132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => Small molecules for inducing selective protein degradation and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/969772
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 50
[patent_no_of_words] => 53938
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1993
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16969772
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/969772 | Small molecules for inducing selective protein degradation and uses thereof | Feb 21, 2019 | Issued |
Array
(
[id] => 14467567
[patent_doc_number] => 20190185426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => NEW TRIFLUOROMETHYLPROPANAMIDE DERIVATIVES AS HTRA1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/283640
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16283640
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/283640 | Trifluoromethylpropanamide derivatives as HTRA1 inhibitors | Feb 21, 2019 | Issued |
Array
(
[id] => 14836093
[patent_doc_number] => 20190276447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => INDAZOLYL-1,2,4-THIADIAZOLAMINES AND RELATED COMPOUNDS FOR INHIBITION OF RHO-ASSOCIATED PROTEIN KINASE AND THE TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/275426
[patent_app_country] => US
[patent_app_date] => 2019-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28191
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16275426
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/275426 | Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease | Feb 13, 2019 | Issued |
Array
(
[id] => 16495996
[patent_doc_number] => 10862051
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications
[patent_app_type] => utility
[patent_app_number] => 16/275678
[patent_app_country] => US
[patent_app_date] => 2019-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15108
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 787
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16275678
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/275678 | Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications | Feb 13, 2019 | Issued |
Array
(
[id] => 14438787
[patent_doc_number] => 20190177265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => METHOD FOR COUPLING A FIRST COMPOUND TO A SECOND COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/271008
[patent_app_country] => US
[patent_app_date] => 2019-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16271008
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/271008 | METHOD FOR COUPLING A FIRST COMPOUND TO A SECOND COMPOUND | Feb 7, 2019 | Abandoned |
Array
(
[id] => 16452498
[patent_doc_number] => 20200361924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => FUSED THIOPHENE DERIVATIVES AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 16/967746
[patent_app_country] => US
[patent_app_date] => 2019-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967746
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967746 | Fused thiophene derivatives and their uses | Feb 7, 2019 | Issued |
Array
(
[id] => 16688297
[patent_doc_number] => 20210070773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => 4-HYDROXYPIPERIDINE DERIVATIVES AND THEIR USE AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 19 (USP19)
[patent_app_type] => utility
[patent_app_number] => 16/965403
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 368
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965403
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/965403 | 4-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specific protease 19 (USP19) | Jan 30, 2019 | Issued |